Company: FSTWF
Filing Date: 2025-02-28
Form Type: F-1
Source: 0001213900-25-018264
Chunk: 38

Company: FST Corp.
Filing Date: 2025-02-28
Form: F-1
Chunk 38
---
 any such acquisition or investment. Any such issuances of additional share capital may cause shareholders to experience significant dilution of their ownership interests and the per share value of FST Ordinary Shares to decline. 19 FST does not have any definite timetable for the payment of any dividends, and as a result, your ability to achieve a return on your investment may depend on appreciation in the price of FST Ordinary Shares. FST does not have any definite timetable for the payment of any dividends, and any determination to pay dividends in the future will be at the discretion of its board of directors. Accordingly, you may need to rely on sales of FST Ordinary Shares after price appreciation, which may never occur, as the only way to realize any future gains on your investment. Sales of a substantial number of our securities in the public market by our existing shareholders could cause the price of the Ordinary Shares and Warrants to fall, and certain Selling Securityholders may earn a positive rate of return on their investment, even if certain other shareholders experience a negative rate of return. Sales of substantial amounts of the Ordinary Shares in the public market or the perception that these sales could occur, could adversely affect the market price of the Ordinary Shares and could materially impair our ability to raise capital through equity offerings in the future. This prospectus relates to, among other things, the issuance from time to time by us of up to 14,399,985 Ordinary Shares upon the exercise of 14,399,985 Warrants. This prospectus also relates to the resale from time to time by the Selling Securityholders of up to 35,184,834 Ordinary Shares. As of the date of this prospectus, our issued share capital consists of (1) 44,766,003 Ordinary Shares and (2) 14,399,985 Warrants. The Selling Securityholders can sell, under this prospectus, up to 35,184,834 Ordinary Shares, constituting approximately 78.60% of the issued and outstanding Ordinary Shares as of the date of this prospectus and approximately 59.47% of the issued and outstanding Ordinary Shares, assuming all Warrants are exercised in full. See “ Shares Eligible for Future Sales” for more details. Sales of a substantial number of Ordinary Shares in the public market by the Selling Securityholders and/or by our other existing shareholders, or the perception that those sales might occur, could result in a significant decline in the public trading price of the Ordinary Shares and could impair our ability to raise capital through the sale